Galectin Therapeutics (GALT) Receivables - Net (2010)

Galectin Therapeutics' (GALT) quarterly Receivables - Net came in at $234000.0 in Q4 2010.

Galectin Therapeutics (GALT) Receivables - Net (2010) Analysis & Trends

Galectin Therapeutics' Receivables - Net history runs 1 years deep, the most recent figure standing at $234000.0 for Q4 2010.

On a quarterly basis, Receivables - Net changed N/A year-over-year to $234000.0 in Q4 2010; TTM through Dec 2010 was $234000.0, a N/A change from a year earlier, with the FY2010 full-year figure at $234000.0, changed N/A from the prior year.
Receivables - Net was little changed at $234000.0 in Q4 2010 per GALT's latest filing.
Across five years, Receivables - Net topped out at $234000.0 in Q4 2010 and bottomed at $234000.0 in Q4 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Galectin Therapeutics	227.21 Mn	227.21 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2010	234,000.00
Dec 31, 2010	234,000.00